Clinical Trials in Los Angeles

Showing 2581-2600 of 8,046 trials

A Study of LY3022855 In Participants With Breast or Prostate Cancer

NCT02265536

The main purpose of this study is to learn more about how the investigational drug, LY3022855, affects the immune system in participants with advanced breast or prostate cancer that has not responded to other treatments. Treatment may last up to 6 cycles (cycle = 6 weeks).

NeoplasmsNeoplasm Metastasis

Eli Lilly and Company34 participantsStarted May 2015

Los Angeles, California, United States • New York, New York, United States

COMPLETEDNA< 1 mile

The PRISM Intervention for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation

NCT03640325

Multisite Randomized Controlled Trial (RCT) testing the efficacy of the Promoting Resilience in Stress Management (PRISM) intervention among Adolescents and Young Adults receiving hematopoietic cell transplantation for hematology malignancy.

CancerBone Marrow NeoplasmsAnxiety+5 more

Seattle Children's Hospital143 participantsStarted Apr 2019

Birmingham, Alabama, United States • Los Angeles, California, United States • Boston, Massachusetts, United States +2 more locations

Active Not RecruitingNA< 1 mile

Enhancing BodyWorks: a Canine Health Literacy Module

NCT04516252

Dog ownership can serve as a vehicle for large-scale multi-level public health interventions, especially for pediatric overweight and obesity, due to dogs' unique place in children and adolescents' social networks.This study develops and tests a novel approach to design a Canine Health-Literacy module to enhance a Comprehensive Family Lifestyle Intervention BodyWorks, for dog-owning adolescents who have been diagnosed with overweight or obesity, and their parents. The results are anticipated to make an important step towards addressing the overweight and obesity epidemic among both people and companion dogs in the U.S.

Overweight and ObesityOverweight Adolescents

Children's Hospital Los Angeles208 participantsStarted Feb 2021

Los Angeles, California, United States

A Study of LY3022855 In Participants With Breast or Prostate Cancer

The PRISM Intervention for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation

Enhancing BodyWorks: a Canine Health Literacy Module

Find Trials by Condition in Los Angeles

A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus

In-home Obesity Prevention to Reach Low-income Infants

TriVerity in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected Sepsis

Stockholm3 Validation Study in a Multi-Ethnic Cohort

Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19

Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis

Assess Aesthetic Improvement and Onset of QM1114-DP in Subjects With Moderate to Severe Glabellar Lines

Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants

Study to Learn How Different Forms of The Study Medicine Called Danuglipron Are Taken up Into the Blood In Healthy Adults

A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19

Can Single-Injection Adductor Canal Blocks Improve PostOp Pain Relief in Patients Undergoing Total Knee Arthroplasty?

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6)

A Study to Evaluate the Safety of Long-term Ivacaftor Treatment in Participants With Cystic Fibrosis Who Are Less Than 24 Months of Age at Treatment Initiation and Have an Approved Ivacaftor-Responsive Mutation

High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant

Investigation of Clot in Ischemic Stroke and Hematoma Evacuation

A Study of Atezolizumab Compared With a Single-Agent Chemotherapy in Treatment Naïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable For Platinum-Doublet Chemotherapy

Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms